Zilretta
006-C-202
Phase 2 small_molecule terminated
Quick answer
Zilretta for Osteoarthritis of Hip is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Osteoarthritis of Hip
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated